Empirical Asset Management, LLC Candel Therapeutics, Inc. Transaction History

Empirical Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$0.91 - $1.3 $910 - $1,300	-1,000 Reduced 9.09%	10,000 $9,000
Q2 2023 Aug 01, 2023	SELL	$1.2 - $1.78 $1,200 - $1,780	-1,000 Reduced 8.33%	11,000 $13,000
Q1 2022 May 06, 2022	BUY	$3.66 - $8.0 $43,920 - $96,000	12,000 New	12,000 $61,000

6.41M

109K

130K

Ticker CADL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,891,900
Market Cap $256M
Description
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Empirical Asset Management, LLC with notifications on news.